Details for Patent: 12,534,530
Which drugs does patent 12,534,530 protect, and when does it expire?
Patent 12,534,530 protects INLYTA and is included in one NDA.
Protection for INLYTA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty-one patent family members in twenty-two countries.
Summary for Patent: 12,534,530
| Title: | Combination of a PD-1 antagonist and a VEGFR inhibitor for treating cancer |
| Abstract: | The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a VEGFR inhibitor, and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express PD-L1. |
| Inventor(s): | Jean-Francois Andre Martini, Jamal Christo Tarazi, Rodolfo Fleury Perini, David J. Mauro |
| Assignee: | Merck Sharp and Dohme LLC , Pfizer Inc |
| Application Number: | US17/725,240 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 12,534,530
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pf Prism Cv | INLYTA | axitinib | TABLET;ORAL | 202324-001 | Jan 27, 2012 | AB | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Pf Prism Cv | INLYTA | axitinib | TABLET;ORAL | 202324-002 | Jan 27, 2012 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,534,530
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2015214390 | ⤷ Start Trial | |||
| Brazil | 112016017256 | ⤷ Start Trial | |||
| Canada | 2937521 | ⤷ Start Trial | |||
| Canada | 3210360 | ⤷ Start Trial | |||
| China | 105960415 | ⤷ Start Trial | |||
| China | 118286440 | ⤷ Start Trial | |||
| Cyprus | 1121374 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
